ArticleThe Journal of experimental medicine2014

TPL2 mediates autoimmune inflammation through activation of the TAK1 axis of IL-17 signaling.

Yichuan Xiao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.